loadpatents
name:-0.14323210716248
name:-0.0077998638153076
name:-0.004086971282959
Shih; David Q. Patent Filings

Shih; David Q.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shih; David Q..The latest application filed is for "mitigation and reversal of fibrosis and inflammation by inhibition of tl1a function and related signaling pathways".

Company Profile
2.5.7
  • Shih; David Q. - La Crescenta CA
  • Shih; David Q. - Los Angeles CA
  • Shih; David Q. - New York NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of TL1A function
Grant 11,434,296 - Shih , et al. September 6, 2
2022-09-06
Mitigation And Reversal Of Fibrosis And Inflammation By Inhibition Of Tl1a Function And Related Signaling Pathways
App 20200190203 - Shih; David Q. ;   et al.
2020-06-18
Treatment and reversal of fibrosis and inflammation by inhibition of the TL1A-DR3 signaling pathway
Grant 10,633,449 - Shih , et al.
2020-04-28
Models, Methods And Compositions For Treating Inflammatory Bowel Disease
App 20180156781 - SHIH; David Q. ;   et al.
2018-06-07
TL1A model of inflammation fibrosis and autoimmunity
Grant 9,332,741 - Shih , et al. May 10, 2
2016-05-10
Distinct Effects Of Ifn-gamma And Il-17 On Tl1a Modulated Inflammation And Fibrosis
App 20160096885 - Shih; David Q. ;   et al.
2016-04-07
Mitigation And Reversal Of Fibrosis And Inflammation By Inhibition Of Tl1a Function And Related Signaling Pathways
App 20160060335 - Shih; David Q. ;   et al.
2016-03-03
Tl1a Model Of Inflammation Fibrosis And Autoimmunity
App 20150026831 - Shih; David Q. ;   et al.
2015-01-22
TL1A model of inflammation fibrosis and autoimmunity
Grant 8,766,034 - Shih , et al. July 1, 2
2014-07-01
Tl1a Model Of Inflammation Fibrosis And Autoimmunity
App 20120079611 - Shih; David Q. ;   et al.
2012-03-29
Methods for inhibiting adipogenesis and for treating type 2 diabetes
App 20070166710 - Stoffel; Markus ;   et al.
2007-07-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed